Disease Description
Basal cell carcinoma's (BCC) are abnormal, uncontrolled growths or lesions that arise in the skin’s basal cells. Basal cells are cells which line the outermost layer of the skin. BCCs often have the appearance of open sores, red patches, pink growths, shiny bumps, or scars. They are usually caused by a combination of cumulative UV light exposure and intense, occasional UV light exposure. BCC’s can be highly disfiguring if allowed to grow, but almost never spreads (metastasizes) beyond the original tumor site to become a life threatening disease. [1]
Prevalence
Estimates of the incidence of BCC are imprecise since there is no cancer registry that collects data on BCC. The American Cancer society estimates that more than two million nonmelanoma skin cancers were treated in the United States in 2006, of which the majority would have been BCC [2]
Current Treatment Options
For superficial low-risk Basal Cell Carcinoma lesions treatment options include surgical excision, or topical treatment with topical 5-fluorouracil or imiquimod.[3]
Evidence for and the Proposed Mechanism for Cannabinoid Threapies
Accumulating recent evidence implicates the endocannabinoid system in the regulation of growth of skin cells. Casanova et al. have demonstrated that various human skin tumors (e.g. basal cell carcinoma, squamous cell carcinoma) express cannabinoid receptors both CB1 and CB2. Local administration of synthetic CB1 and CB2 agonists induced growth inhibition of malignant skin tumors in mice. This growth inhibition was accompanied by enhanced intra-tumor cell death and impaired tumor vascularization (altered blood vessel morphology, decreased expression of pro-angiogenic factors such as VEGF, placental growth factor and angiopoietin 2) [4]
1. Skin Cancer Foundation. www.skincancer.org/
2. American Cancer Society Cancer Facts and Figures 2010.
3. UpToDate Online resources. Uptodate.com
4. Pacher, P. et al. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. Aug 2009; 30(8): 411–420.
We are LIVE !!! Join the FIGHT NOW! with Harvard Award Winning,
Low-Cost Cancer-Killing Treatments! Click the Above Image link to setup your Account and begin your Crypto Journey with us. The 1-Million Strong Killing Cancers Foundation, the 1-Million Strong Fight Club, & CSi Labs are making cancer treatments affordable and accessible for millions of patients through our innovative cancer killing fundraising meme token. All Crypto MEME Coin Purchases will be included in the Up and Coming Contests and Promotions!
The Time is Now. 1-Million Strong Killing Cancers!
Click the Below Image to Review our Cancer Drug Comparables
*** Warning this document contains graphic images.
CSi-VIP Awards & NASDAQ Updates
Please Click the Below Image:



The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Please Click the Below Calendar image to book your time to speak with Mr. Dabney about Your CSi-VIP Shareholder Legacy & 1-Million Strong Membership.
One LAST TIME … for CLARITY …
CBIS Original Shareholders - CBIS First Rights, CSi-VIP Bonus Shares, CBIS GIFT Shares, CSi-VIP Drug Ownership Program ...
*** CSi-VIP AWARDS Program !!!
MAKE SURE … You have Your CSi-VIP Membership!

Click the Above image: February 4, 2026, Cannabis Science Inc., Shareholder Close-out. All Cannabis Science Shareholders Qualify.
Above ANNOUNCEMENT: December 31, 2025, Cannabis Science Inc., Shareholder Close-out.
Cannabis Science Financials & FINAL CBIS/CSi-VIP Share Numbers. Click the above Image link to view the latest Report.
November 5, 2025
Cannabis Science Shareholder FINAL Audit Confirmations
Click the above Image link to view the latest Report
September 23, 2025
Cannabis Science Shareholder Audit Confirmations Underway now!
Click the above Image link to view the latest Report.
July 7, 2025
Click the above Image link to view the latest cancer Killing promotional video. This is where you can join our 1-Million Strong youtube page to view more videos as we proceed forward.
June 1, 2025, Pre-Launch Success
Click the above Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time offer!
*** Warning this document contains exciting images.
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.

2025 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2025
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,839,095,296
Fully Diluted:
4,510,547,648
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
RAYMOND, PLEASE RESPOND TO MY EMAIL! ...Francis G. Cormier III
In 2021, a share exchange was initiated through Thermic Science International...RAYMOND, PLEASE RESPOND TO MY EMAIL! ...Francis G. Cormier III
In 2021, a share exchange was initiated through Thermic Science International Corporation, which acquired Cannabis Science Inc and created new share classes for former shareholders. This transaction effectively transitioned Cannabis Science into a private entity under the Thermic Science umbrella, with the stock trading.
Cannabis Science Inc (formerly CBIS) is delisted and no longer publicly traded, with its shares effectively cancelled following SEC actions.
Delisting and SEC Actions
Cannabis Science Inc was delisted by the SEC due to delinquent filings and failure to meet reporting requirements, after a period of suspension and administrative placement on the Grey Market. The company’s shares were cancelled, and there is no active public trading under its former ticker CBIS (Cannabis Science Inc). The delisting followed regulatory sanctions imposed in October 2019, when the company failed to file timely financial reports, leading to its privatization.
Privatization and Share Exchange
After going private, Cannabis Science ceased issuing quarterly results or investor communications, leaving former shareholders without liquidity. In 2021, a share exchange was initiated through Thermic Science International Corporation, which acquired Cannabis Science Inc and created new share classes for former shareholders. This transaction effectively transitioned Cannabis Science into a private entity under the Thermic Science umbrella, with the stock trading symbol ENDO for the new entity
Current Status
As of 2026, Cannabis Science Inc operates as a private company focused on medical marijuana research and development, including phytocannabinoid-based pharmaceutical products. The company is headquartered in Irvine, California, and has a small team of employees. It continues to engage in research, joint ventures, and corporate development, but its former public shares are no longer active or tradable
Key Takeaways
Cannabis Science Inc is permanently delisted and no longer publicly traded
SEC sanctions and failure to file financial reports were the primary reasons for delisting
Former shareholders may participate in the Thermic Science share exchange, but the original CBIS shares are cancelled.
The company now operates privately, focusing on cannabinoid-based pharmaceutical research.
Investors should note that there is no public market liquidity for the original Cannabis Science shares, and any potential investment would involve the private entity under Thermic Science International Corporation.
Show more